BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 8029909)

  • 1. Graft adaptation in hamster-to-rat cardiac xenografts.
    Hasan RI; Sriwatanawangosa V; Wallwork J; White DJ
    Transplant Proc; 1994 Jun; 26(3):1282-3. PubMed ID: 8029909
    [No Abstract]   [Full Text] [Related]  

  • 2. Consistent prolonged "concordant" survival of hamster-to-rat cardiac xenografts by inhibition of anti-species antibodies with methotrexate.
    Hasan RI; Sriwatanawongsa V; Wallwork J; White DJ
    Transplant Proc; 1993 Feb; 25(1 Pt 1):421-2. PubMed ID: 8438362
    [No Abstract]   [Full Text] [Related]  

  • 3. Long-term xenograft survival and suppression of xenoantibody formation in the hamster-to-rat heart transplant model using a combination therapy of leflunomide and cyclosporine.
    Lin Y; Sobis H; Vandeputte M; Waer M
    Transplant Proc; 1994 Dec; 26(6):3202. PubMed ID: 7998115
    [No Abstract]   [Full Text] [Related]  

  • 4. Prolonged survival of hamster to rat heart xenografts with cyclophosphamide therapy.
    Hasan RI; van den Bogaerde J; Forty J; Wright L; Wallwork J; White DJ
    Transplant Proc; 1992 Apr; 24(2):517-8. PubMed ID: 1566412
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of leflunomide in control of acute rejection in hamster-to-rat cardiac xenografts.
    Xiao F; Chong A; Foster P; Sankary H; McChesney L; Williams JM; Frieders D; Williams JW
    Transplant Proc; 1994 Jun; 26(3):1263-5. PubMed ID: 8029902
    [No Abstract]   [Full Text] [Related]  

  • 6. Prolonged survival of cardiac xenografts between widely divergent species: bird to mammal.
    Braidley PC; Wallwork J; White DJ
    Transplant Proc; 1995 Feb; 27(1):307-8. PubMed ID: 7879013
    [No Abstract]   [Full Text] [Related]  

  • 7. Combination therapy with Brequinar sodium and cyclosporine synergistically prolongs hamster-to-rat cardia xenograft survival.
    Cosenza CA; Cramer DV; Tuso PJ; Chapman FA; Wang HK; Makowka L
    J Heart Lung Transplant; 1994; 13(3):489-97. PubMed ID: 8061026
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Continuous administration of methyldeoxyspergualin prolongs xenograft survival in hamster-to-rat cardiac transplantation.
    Suzuki S; Nishimori H; Kido K; Arita S; Tashiro H; Ohdan H; Quiñones D; Amemiya H
    Transplant Proc; 1993 Feb; 25(1 Pt 1):430-1. PubMed ID: 8438365
    [No Abstract]   [Full Text] [Related]  

  • 9. Recipient pretreatment permits long-term xenograft survival on a relatively low dose cyclosporine maintenance therapy.
    Bouwman E; de Bruin RW; Jeekel J; Marquet RL
    Transplant Proc; 1992 Apr; 24(2):519-20. PubMed ID: 1566413
    [No Abstract]   [Full Text] [Related]  

  • 10. Mechanisms involved in long-term hamster-to-rat cardiac xenograft survival.
    Lin Y; Vandeputte M; Waer M
    Transplant Proc; 1996 Apr; 28(2):683. PubMed ID: 8623343
    [No Abstract]   [Full Text] [Related]  

  • 11. Treatment strategies of hamster-to-rat cardiac xenotransplantation.
    Steinbrüchel DA; Nielsen B; Kemp E
    Transplant Proc; 1994 Apr; 26(2):1039-41. PubMed ID: 8171460
    [No Abstract]   [Full Text] [Related]  

  • 12. Induction therapy of leflunomide and cyclosporine allows for long-term xenograft survival under cyclosporine alone.
    Lin Y; Sobis H; Vandeputte M; Waer M
    Transplant Proc; 1994 Oct; 26(5):3052. PubMed ID: 7940959
    [No Abstract]   [Full Text] [Related]  

  • 13. The effect of a new immunosuppressive drug, brequinar sodium, on concordant hamster-to-rat cardiac xenografts.
    Cramer DV; Chapman FA; Jaffee BD; Eiras-Hreha G; Yasunaga C; Wu GD; Makowka L
    Transplant Proc; 1992 Apr; 24(2):720-1. PubMed ID: 1566499
    [No Abstract]   [Full Text] [Related]  

  • 14. Mechanism of leflunomide-induced prevention of xenoantibody formation and xenograft rejection in the hamster to rat heart transplantation model.
    Lin Y; Sobis H; Vandeputte M; Waer M
    Transplant Proc; 1995 Feb; 27(1):305-6. PubMed ID: 7879012
    [No Abstract]   [Full Text] [Related]  

  • 15. Control and reversal of chronic xenograft rejection in hamster-to-rat cardiac transplantation.
    Xiao F; Shen J; Chong A; Liu W; Foster P; Blinder HL; Sankary H; McChesney L; Mital D; Williams JW
    Transplant Proc; 1996 Apr; 28(2):691-2. PubMed ID: 8623348
    [No Abstract]   [Full Text] [Related]  

  • 16. Survival of hamster heart xenografts in rat recipients on a relatively mild immunosuppressive protocol.
    Scheringa M; Töns A; Bouwman E
    Transplant Proc; 1996 Apr; 28(2):833-4. PubMed ID: 8623423
    [No Abstract]   [Full Text] [Related]  

  • 17. Graft survival in a hamster-to-rat heart transplantation model after treatment with total lymphoid irradiation, cyclosporine A, and a monoclonal anti-T-cell antibody.
    Steinbrüchel DA; Madsen HH; Nielsen B; Kemp E; Larsen S; Koch C
    Transplant Proc; 1990 Jun; 22(3):1088. PubMed ID: 2349667
    [No Abstract]   [Full Text] [Related]  

  • 18. Long-term survival of disparate cardiac xenografts: induction of tolerance and humoral accommodation.
    Thomas F; Araneda D; Quarantillo P
    Transplant Proc; 1994 Jun; 26(3):1220-3. PubMed ID: 8029894
    [No Abstract]   [Full Text] [Related]  

  • 19. Synergistic effect of donor pretreatment using FK 506 in hamster-to-rat cardiac xenotransplantation.
    Hayashi S; Ito M; Yokoyama I; Uchida K; Takagi H
    Transplant Proc; 1994 Jun; 26(3):1284. PubMed ID: 7518126
    [No Abstract]   [Full Text] [Related]  

  • 20. Prolonged survival of hamster-to-rat pulmonary xenografts by tacrolimus (FK506) and cyclophosphamide.
    Komatsu K; Youm W; Konishi H; Kawaharada N; Yousem SA; Murase N; Griffith BP; Pham SM
    J Heart Lung Transplant; 1996 Jul; 15(7):722-7. PubMed ID: 8820789
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.